関連する実験動画
Updated: Feb 14, 2026

08:31
Three-dimensional Alginate-bead Culture of Human Pituitary Adenoma Cells
Published on: February 18, 2016
10.5K
肝腺腫の非手術的管理:レビュー
Ian C Garbarine1, Jordan M Cloyd2
1Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, 43210, USA.
Journal of gastrointestinal cancer
|February 12, 2026
まとめ
肝腺腫 (HAs) は良性肝臓腫瘍である. 体重減少とアクティブ・サーベイランスを含む非手術戦略は,HAの管理において,大きなHAであっても,リスクを軽減し,患者のアウトカムを最適化するためにますます効果的です.
科学分野:
- 肝臓病理学 肝臓病理学
- 胃腸内科 胃腸内科
- 腫瘍学 腫瘍学
背景:
- 肝腺腫 (HAs) は一般的な良性肝臓腫瘍です.
- 腫瘍の大きさ,出血,悪性変異が主なリスクである.
- 肥満は,HAの発達と成長のための新たなリスク要因です.
研究 の 目的:
- 肝臓腺腫の現在のおよび新興の治療戦略をレビューする.
- 非運用管理の拡大する役割を強調する.
- HA患者に対するパーソナライズされた,多学科的なケアを強調する.
主な方法:
- 肝アデノマ管理に関する現在の文献のレビュー.
- 腫瘍の大きさや肥満を含む危険因子の分析.
- 外科的および非手術的治療方法の評価.
主要な成果:
- 大きな,症状のある,または高リスクのHAの場合は,手術による切除が標準です.
- アクティブ・サーベイランスは,小規模で無症状のHAに適しています.
- 体重減少介入や局所地域療法を含む非手術戦略は,様々なHAサイズに対して有効性を示しています.
結論:
- 非運用的な管理は,大きなHA (>5cm) の場合でも拡大しています.
- 減量介入はHAのサイズを大幅に減らす.
- パーソナライズされた,多学科的なアプローチは,最適なHA患者のケアに不可欠です.
関連する概念動画
Review and Preview
8.4K
In statistics, several tools are used to interpret the data. Measures of central tendency represent the characteristics of the data, such as mean, median, and mode. Additionally, measures of variance like standard deviation and range are used to find the spread of data from the mean. Relative standing measures the distance between data locations. Commonly used measures of relative standings are percentile, z score, and quartiles.
Percentiles are a type of fractile that partition data into...
Percentiles are a type of fractile that partition data into...
8.4K
Review and Preview
11.6K
Data are individual items of information obtained from a population or sample. Data may be classified as qualitative (categorical), quantitative continuous, or quantitative discrete. Because it is not practical to measure the entire population in a study, researchers use samples to represent the population. A random sample is a representative group from the population chosen by using a method that gives each individual in the population an equal chance of being included in the sample. Random...
11.6K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
281
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
281
Hepatic Portal System
6.3K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
6.3K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
255
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
255
Tonsillitis II: Management
446
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
446

